An Emerging Strategy for Cancer Treatment Targeting Aberrant Glycogen Synthase Kinase 3&bgr;

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|9|10|1114-1122

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.9, Iss.10, 2009-01, pp. : 1114-1122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Aberrant TGF-&bgr; Signaling in Pre-Clinical Models of Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 7, Iss. 5, 2007-01 ,pp. : 504-514

Bentham Science Publishers

Access to resources Recommend Favorite

Association of glycogen synthase kinase3β with Parkinson's disease (Review)

By          

Molecular Medicine Reports, Vol. 9, Iss. 6, 2014-01 ,pp. : 2043-2050

Spandidos Publications

Access to resources Recommend Favorite

miRNA-99b-3p functions as a potential tumor suppressor by targeting glycogen synthase kinase-3β in oral squamous cell carcinoma Tca-8113 cells

By                        

International Journal of Oncology, Vol. 47, Iss. 4, 2015-01 ,pp. : 1528-1536

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of glycogen synthase kinase-3β attenuates acute kidney injury in sodium taurocholateinduced severe acute pancreatitis in rats

By  

Molecular Medicine Reports, Vol. 10, Iss. 6, 2014-01 ,pp. : 3185-3192

Spandidos Publications

Access to resources Recommend Favorite

Upregulation of C-C chemokine receptor type 7 expression by membrane-associated prostaglandin E synthase-1/prostaglandin E2 requires glycogen synthase kinase 3β-mediated signal transduction in colon cancer cells

By          

Molecular Medicine Reports, Vol. 12, Iss. 5, 2015-01 ,pp. : 7169-7175

Spandidos Publications

Access to resources Recommend Favorite